Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03145207 · ClinicalTrials.gov registry record · Early Phase 1
PK and DPK of Lidocaine Dermal Products
A Early Phase 1 study of Heat Effect, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 14
- Enrollment target
- 1
- Study location
NCT03145207 is a Early Phase 1 study of Heat Effect that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 14 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03145207, a Early Phase 1 study of Heat Effect, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a bioequivalence study to compare lidocaine release between a brand name and generic skin patches in healthy adults.
Conditions Studied
Interventions
- DRUG Lidocaine patch
Study Locations (1)
Maryland
- General Clinical Research Center (GCRC) at the University of - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2016-12-14 |
| Est. Completion | 2020-05-15 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03145207
The ClinicalTrials.gov registry entry for NCT03145207 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heat Effect appearing as the primary indexed condition, and to 1 intervention - of which Lidocaine patch is the first listed.
NCT03145207 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT03145207 about?
NCT03145207 is a clinical study titled "PK and DPK of Lidocaine Dermal Products". This is a bioequivalence study to compare lidocaine release between a brand name and generic skin patches in healthy adults.
What is the current status of trial NCT03145207?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 14 participants. The study started on 2016-12-14. Estimated completion is 2020-05-15.
What conditions does trial NCT03145207 study?
This clinical trial studies the following conditions: Heat Effect.
What interventions are being tested in trial NCT03145207?
The interventions under investigation include: Lidocaine patch (DRUG).
Who is sponsoring clinical trial NCT03145207?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03145207 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heat Effect
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.